Drugs / Perinatal Tissue Mesenchyme Stem Cells
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04034615 | May → Dec 2021 | — | Maternal and Child Health Hospital of Foshan | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT02772289 | Nov 2016 → Sep 2018 | — | Maternal and Child Health Hospital of Foshan | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Perinatal Tissue Mesenchyme Stem Cells | “Participants will receive transdermal one dose of 1\*10\^6 cells of Perinatal Tissue Mesenchyme Stem Cells in the gel once a day for continuous three days” NCT02772289 ↗1“Perinatal Tissue Mesenchyme Stem Cells” NCT04034615 ↗ |
| Route | Other | “receive transdermal one dose of 1\*10\^6 cells of Perinatal Tissue Mesenchyme Stem Cells” NCT02772289 ↗ |